"Anti-Allergic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)
| Descriptor ID |
D018926
|
| MeSH Number(s) |
D27.505.954.016
|
| Concept/Terms |
Anti-Allergic Agents- Anti-Allergic Agents
- Agents, Anti-Allergic
- Anti Allergic Agents
- Anti-Allergy Drugs
- Anti Allergy Drugs
- Drugs, Anti-Allergy
- Antiallergy Agents
- Agents, Antiallergy
- Antiallergic Drugs
- Drugs, Antiallergic
- Antiallergics
- Anti-Allergics
- Anti Allergics
- Antiallergic Agents
- Agents, Antiallergic
|
Below are MeSH descriptors whose meaning is more general than "Anti-Allergic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Allergic Agents".
This graph shows the total number of publications written about "Anti-Allergic Agents" by people in this website by year, and whether "Anti-Allergic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 2 | 4 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Allergic Agents" by people in Profiles.
-
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
-
Chronic Follicular Conjunctivitis in a Middle-aged Woman. JAMA Ophthalmol. 2018 07 01; 136(7):833-834.
-
Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opin Pharmacother. 2017 Aug; 18(11):1137-1143.
-
Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg. 2015 Feb; 152(1 Suppl):S1-43.
-
Chronic idiopathic urticaria: treatment with omalizumab. Skin Therapy Lett. 2014 Nov-Dec; 19(6):1-4.
-
Medically reversible limbal stem cell disease: clinical features and management strategies. Ophthalmology. 2014 Oct; 121(10):2053-8.
-
Should clinicians use omalizumab for the treatment of nasal polyps? J Allergy Clin Immunol. 2013 Jul; 132(1):247.
-
Amaranthus spinosus Linn. inhibits mast cell-mediated anaphylactic reactions. J Immunotoxicol. 2012 Jan-Mar; 9(1):77-84.
-
Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis. Expert Opin Drug Metab Toxicol. 2011 Dec; 7(12):1593-9.
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.